• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma.

作者信息

De Menis E, Da Rin G, Roiter I, Legovini P, Foscolo G, Conte N

机构信息

Divisione Medica, Ospedale Regionale di Treviso, Italy.

出版信息

Horm Res. 1992;37(6):217-20. doi: 10.1159/000182315.

DOI:10.1159/000182315
PMID:1292974
Abstract

Parameters of bone turnover were measured in 20 premenopausal women affected by autonomous thyroid adenoma: 7 patients were suffering from overt hyperthyroidism with raised values of free thyroid hormones; 13 were clinically euthyroid and had normal values of free thyroid hormones. In all cases serum TSH concentrations were below the lower normal limit of our laboratory (< 0.4 mU/l). Eleven healthy premenopausal women were studied as a control group. Patients with overt hyperthyroidism disclosed a significant enhancement of both bone resorption (increased serum calcium and urinary excretion of hydroxyproline) and bone formation (increased serum levels of osteocalcin and alkaline phosphatase) when compared both to controls and to patients with subclinical hyperthyroidism. No significant alterations of bone metabolism parameters were found in patients with subclinical hyperthyroidism in comparison with controls. Therefore, in premenopausal women affected by autonomous thyroid adenoma the bone turnover appeared to be significantly increased when the serum values of free thyroid hormones were raised in the group of patients with overt hyperthyroidism.

摘要

相似文献

1
Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma.
Horm Res. 1992;37(6):217-20. doi: 10.1159/000182315.
2
[Serum osteocalcin in hyperthyroidism].[甲状腺功能亢进症中的血清骨钙素]
Ann Ital Med Int. 1990 Apr-Jun;5(2):95-9.
3
Bone remodelling markers and serum cytokines in patients with hyperthyroidism.甲状腺功能亢进患者的骨重塑标志物与血清细胞因子
Clin Endocrinol (Oxf). 2002 Jul;57(1):125-9. doi: 10.1046/j.1365-2265.2002.01578.x.
4
Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women.内源性亚临床甲状腺功能亢进对绝经前女性骨代谢和骨密度的影响。
Thyroid. 1999 Jun;9(6):539-43. doi: 10.1089/thy.1999.9.539.
5
Sclerostin and bone metabolism markers in hyperthyroidism before treatment and interrelations between them.甲状腺功能亢进症治疗前的硬化蛋白与骨代谢标志物及其相互关系。
Acta Biochim Pol. 2017;64(4):597-602. doi: 10.18388/abp.2016_1303. Epub 2017 Oct 25.
6
Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study.甲状腺功能异常患者和甲状腺功能正常对照组的骨转换生化标志物:一项横断面研究。
Clin Chim Acta. 1999 Nov;289(1-2):159-72. doi: 10.1016/s0009-8981(99)00173-4.
7
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.亚临床甲状腺功能亢进的格雷夫斯病患者骨转换持续增加。
J Clin Endocrinol Metab. 2000 Nov;85(11):4157-61. doi: 10.1210/jcem.85.11.6979.
8
Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.甲状腺素治疗对促甲状腺激素水平正常或受抑制的替代治疗的甲状腺功能减退患者骨代谢的影响。
J Endocrinol Invest. 1991 Jun;14(6):451-5. doi: 10.1007/BF03346838.
9
Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy.抗甲状腺治疗前后甲状腺功能亢进患者的血清骨钙素水平
Tohoku J Exp Med. 2004 Jul;203(3):183-8. doi: 10.1620/tjem.203.183.
10
Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.通过47Ca动力学评估骨转换。血清骨γ-羧基谷氨酸蛋白、血清碱性磷酸酶及尿羟脯氨酸排泄的效能。
J Clin Invest. 1985 Dec;76(6):2254-8. doi: 10.1172/JCI112234.

引用本文的文献

1
Clinical thyroidology: beyond the 1970s' TSH-T4 Paradigm.临床甲状腺学:超越20世纪70年代的促甲状腺激素-甲状腺素范式
Front Endocrinol (Lausanne). 2025 Jun 24;16:1529791. doi: 10.3389/fendo.2025.1529791. eCollection 2025.
2
Expanding the Role of Thyroid-Stimulating Hormone in Skeletal Physiology.拓展促甲状腺激素在骨骼生理学中的作用
Front Endocrinol (Lausanne). 2017 Oct 3;8:252. doi: 10.3389/fendo.2017.00252. eCollection 2017.
3
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.
2015年欧洲甲状腺协会关于内源性亚临床甲状腺功能亢进症诊断和治疗的指南。
Eur Thyroid J. 2015 Sep;4(3):149-63. doi: 10.1159/000438750. Epub 2015 Aug 26.
4
Metabolic and clinical consequences of hyperthyroidism on bone density.甲状腺功能亢进对骨密度的代谢和临床影响。
Int J Endocrinol. 2013;2013:638727. doi: 10.1155/2013/638727. Epub 2013 Jul 22.
5
Thyroid-stimulating hormone, thyroid hormones, and bone loss.促甲状腺激素、甲状腺激素与骨质流失
Curr Osteoporos Rep. 2009 Jul;7(2):47-52. doi: 10.1007/s11914-009-0009-0.
6
Alkaline phosphatase bone isoenzyme and osteocalcin in the serum of hyperthyroid cats.甲状腺功能亢进猫血清中的碱性磷酸酶骨同工酶和骨钙素
Can Vet J. 1996 Dec;37(12):735-9.